What's the Best Way to Invest $100,000 Right Now?
As always, The Motley Fool cannot and does not provide personalized investing or financial advice. This information is for informational and educational purposes only and is not a substitute for professional financial advice.
Prediction: Bitcoin Will Double in Value By 2030
More use cases will drive more economic value for crypto, and Bitcoin is at the front of the line to benefit.
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
11 of 12 participants ( 92% ) enrolled in the 180mg cohort achieved a complete response ...
Meta In Talks To Invest Over $10B In Scale AI - Possibly The Biggest Private AI Deal This Year - Microsoft ( NASDAQ:MSFT ) , Meta Platforms ( NASDAQ:META )
Meta META is reportedly preparing to invest more than $10 billion in Scale AI, a startup providing high-quality labeled data to companies building next-generation AI models, including OpenAI and Microsoft MSFT. If finalized, the deal would rank among the largest private funding rounds in tech ...
Why Are So Many Public Companies Pivoting to Crypto, And What Happens If Bitcoin Crashes?
Although some firms may be forced to sell their Bitcoin if markets cool, others could be acquired by asset managers hunting for deals.
ThinkCareBelieve: Week 21 of America's Progress under President Trump
Washington D.C., June 14, 2025 ( GLOBE NEWSWIRE ) -- You can find the article here: https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/ ThinkCareBelieve has published an article on the 21st week of America under the leadership of President Donald J.
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025 - Celldex Therapeutics ( NASDAQ:CLDX )
77% of patients ( 150 mg Q4W ) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU HAMPTON, N.J., June 14, 2025 ( GLOBE NEWSWIRE ) -- Celldex Therapeutics, Inc.
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
HAMPTON, N.J., June 14, 2025 ( GLOBE NEWSWIRE ) -- Celldex Therapeutics, Inc. ( NASDAQ:CLDX ) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 52 weeks in the Company's Phase 2 clinical trial in chronic spontaneous urticaria ( CSU ) .
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
SINGAPORE, June 14, 2025 ( GLOBE NEWSWIRE ) -- With the price of Bitcoin fluctuating around $100,000, many analysts predict that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to generate short-term profits in such ...
Nimanode Surpasses Crypto Presales, Eyes 10X Growth Post-Launch as Major Investors Flock to the XRP DeFi Landscape
LEEDS, United Kingdom, June 14, 2025 ( GLOBE NEWSWIRE ) -- Nimanode, the first no-code AI agent platform built natively on the XRP Ledger ( XRPL ) , is gaining momentum with its ongoing $NMA token presale.
